Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Tuberculosis

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 45 articles:
HTML format



Single Articles


    January 2024
  1. DONOVAN J, Phu NH, Thwaites GE
    Dexamethasone for Tuberculous Meningitis in HIV-Positive Adults. Reply.
    N Engl J Med. 2024;390:383.
    PubMed    


  2. ELLIS J, Meya DB, Cresswell FC
    Dexamethasone for Tuberculous Meningitis in HIV-Positive Adults.
    N Engl J Med. 2024;390:382-383.
    PubMed    


    October 2023
  3. DONOVAN J, Bang ND, Imran D, Nghia HDT, et al
    Adjunctive Dexamethasone for Tuberculous Meningitis in HIV-Positive Adults.
    N Engl J Med. 2023;389:1357-1367.
    PubMed     Abstract available


  4. WASSERMAN S, Harrison TS
    Tuberculous Meningitis - New Approaches Needed.
    N Engl J Med. 2023;389:1425-1426.
    PubMed    


    August 2023
  5. XIAO K
    Testicular Tuberculosis.
    N Engl J Med. 2023;389:e13.
    PubMed    


    June 2023
  6. PATON NI, Cousins C, Suresh C
    Treatment Strategy for Rifampin-Susceptible Tuberculosis. Reply.
    N Engl J Med. 2023;388:2298.
    PubMed    


  7. LEUNG CC, Migliori GB
    Treatment Strategy for Rifampin-Susceptible Tuberculosis.
    N Engl J Med. 2023;388:2297-2298.
    PubMed    


  8. BOEREE MJ, Heinrich N, Aarnoutse RE
    Treatment Strategy for Rifampin-Susceptible Tuberculosis.
    N Engl J Med. 2023;388:2297.
    PubMed    


  9. BURMAN W, Fox GJ, Horsburgh CR
    Treatment Strategy for Rifampin-Susceptible Tuberculosis.
    N Engl J Med. 2023;388:2296-2297.
    PubMed    


    February 2023
  10. PATON NI, Cousins C, Suresh C, Burhan E, et al
    Treatment Strategy for Rifampin-Susceptible Tuberculosis.
    N Engl J Med. 2023 Feb 20. doi: 10.1056/NEJMoa2212537.
    PubMed     Abstract available


  11. DARTOIS V, Rubin EJ
    Shortening Tuberculosis Treatment - A Strategic Retreat.
    N Engl J Med. 2023 Feb 20. doi: 10.1056/NEJMe2300413.
    PubMed    


  12. AMADO C, Lizarraga KJ
    Tuberculous Optochiasmatic Arachnoiditis.
    N Engl J Med. 2023;388:641.
    PubMed    


    January 2023
  13. CHEN CY, Yang PJ
    Splenic Tuberculosis.
    N Engl J Med. 2023 Jan 21. doi: 10.1056/NEJMicm2206174.
    PubMed    


  14. TIMM J, Crook AM, Sun E
    Regimens for Drug-Resistant Tuberculosis. Reply.
    N Engl J Med. 2023;388:190-191.
    PubMed    


  15. LANGE C, Kohler N, Gunther G
    Regimens for Drug-Resistant Tuberculosis.
    N Engl J Med. 2023;388:190.
    PubMed    


  16. PERUMAL R, Nimmo C, O'Donnell M
    Regimens for Drug-Resistant Tuberculosis.
    N Engl J Med. 2023;388:189.
    PubMed    


    December 2022
  17. NYANG'WA BT, Berry C, Kazounis E, Motta I, et al
    A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis.
    N Engl J Med. 2022;387:2331-2343.
    PubMed     Abstract available


    September 2022
  18. GOSWAMI ND, Ashkin D, Haley CA
    Pretomanid in the Treatment of Patients with Tuberculosis in the United States.
    N Engl J Med. 2022;387:850-852.
    PubMed    


  19. THWAITES G, Nguyen NV
    Linezolid for Drug-Resistant Tuberculosis.
    N Engl J Med. 2022;387:842-843.
    PubMed    


  20. CONRADIE F, Bagdasaryan TR, Borisov S, Howell P, et al
    Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant Tuberculosis.
    N Engl J Med. 2022;387:810-823.
    PubMed     Abstract available


    June 2022
  21. TURKOVA A, Palmer M, Gibb DM
    Shorter Treatment for Tuberculosis in Children. Reply.
    N Engl J Med. 2022;386:2439-2440.
    PubMed    


  22. MISHRA G, Mulani J
    Shorter Treatment for Tuberculosis in Children.
    N Engl J Med. 2022;386:2439.
    PubMed    


  23. CHEN S
    Shorter Treatment for Tuberculosis in Children.
    N Engl J Med. 2022;386:2438-2439.
    PubMed    


    April 2022
  24. MARKS GB, Ho J, Nguyen PTB, Nguyen TA, et al
    A Direct Measure of Tuberculosis Incidence - Effect of Community Screening.
    N Engl J Med. 2022;386:1380-1382.
    PubMed    


    March 2022
  25. SHAH M, Dorman SE
    Latent Tuberculosis Infection. Reply.
    N Engl J Med. 2022;386:e33.
    PubMed    


  26. HOOK EB
    Latent Tuberculosis Infection.
    N Engl J Med. 2022;386:e33.
    PubMed    


  27. ONATE-OCANA LF, Perez-Diaz L
    Intestinal Tuberculosis.
    N Engl J Med. 2022 Mar 26. doi: 10.1056/NEJMicm2114345.
    PubMed    


  28. PHILLIPS PPJ, Kurbatova EV, Dorman SE
    Four-Month Rifapentine Regimens for Tuberculosis. Reply.
    N Engl J Med. 2022;386:1095-1096.
    PubMed    


  29. TAYLOR A, Woodrow C
    Four-Month Rifapentine Regimens for Tuberculosis.
    N Engl J Med. 2022;386:1095.
    PubMed    


  30. PAI M, Zar HJ
    Childhood Tuberculosis - Time for Shorter and Differentiated Treatment.
    N Engl J Med. 2022;386:988-989.
    PubMed    


  31. TURKOVA A, Wills GH, Wobudeya E, Chabala C, et al
    Shorter Treatment for Nonsevere Tuberculosis in African and Indian Children.
    N Engl J Med. 2022;386:911-922.
    PubMed     Abstract available


    January 2022
  32. OMAR SV, Ismail F, Ndjeka N, Kaniga K, et al
    Bedaquiline-Resistant Tuberculosis Associated with Rv0678 Mutations.
    N Engl J Med. 2022;386:93-94.
    PubMed    


  33. PAI M, Kasaeva T, Swaminathan S
    Covid-19's Devastating Effect on Tuberculosis Care - A Path to Recovery.
    N Engl J Med. 2022 Jan 5. doi: 10.1056/NEJMp2118145.
    PubMed    


    December 2021
  34. CATTAMANCHI A, Reza TF, Nalugwa T, Adams K, et al
    Multicomponent Strategy with Decentralized Molecular Testing for Tuberculosis.
    N Engl J Med. 2021;385:2441-2450.
    PubMed     Abstract available


  35. SHAH M, Dorman SE
    Latent Tuberculosis Infection.
    N Engl J Med. 2021;385:2271-2280.
    PubMed    


    August 2021
  36. WHITE A, Thornton RLJ, Greene JA
    Remembering Past Lessons about Structural Racism - Recentering Black Theorists of Health and Society.
    N Engl J Med. 2021;385:850-855.
    PubMed    


    May 2021
  37. RUBIN EJ, Baden LR, Gray GE, Morrissey S, et al
    Audio Interview: Vaccination and Variants in the U.S. and South Africa.
    N Engl J Med. 2021;384:e85.
    PubMed    


  38. RUBIN EJ, Mizrahi V
    Shortening the Short Course of Tuberculosis Treatment.
    N Engl J Med. 2021;384:1764-1765.
    PubMed    


  39. DORMAN SE, Nahid P, Kurbatova EV, Phillips PPJ, et al
    Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis.
    N Engl J Med. 2021;384:1705-1718.
    PubMed     Abstract available


    March 2021
  40. GUNTHER G, Einbeck C
    Pulmonary Alveolar Microlithiasis Complicated by Tuberculosis.
    N Engl J Med. 2021;384:e36.
    PubMed    


    February 2021
  41. HELLMANN DB, Shepard JO, Schaefer PW, Johnson JH, et al
    Case 5-2021: A 68-Year-Old Man with Delirium and Renal Insufficiency.
    N Engl J Med. 2021;384:651-662.
    PubMed    


    January 2021
  42. BEBELL LM, Gonzalez RG, Barczak AK, Anahtar MN, et al
    Case 1-2021: A 76-Year-Old Woman with Lethargy and Altered Mental Status.
    N Engl J Med. 2021;384:166-176.
    PubMed    


    November 2020
  43. ARMAND P, Heeger AP, Kanjilal S, Krystel-Whittemore M, et al
    Case 37-2020: A 35-Year-Old Man with Lymphadenopathy and Petechiae.
    N Engl J Med. 2020;383:2159-2169.
    PubMed    


  44. KUSHWAHA S, Bogoch II, Mak S, Rogalla P, et al
    In the Absence of Proof.
    N Engl J Med. 2020;383:1878-1884.
    PubMed    


    October 2020
  45. TING KC, Wang GS
    Paradoxical Reaction in the Treatment of Scrofula.
    N Engl J Med. 2020;383:1767.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.